05:50:40 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for Sept. 6, 2018

2018-09-06 20:05 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange closed down 3.59 points to 709.56 Thursday. Patrick Langlois's first capital pool shell, Angus Ventures Inc. (GUS: halted), plans to acquire AAA Medic Montreal Inc. for the shell's qualifying transaction. Like many other recent QTs, this is a marijuana deal, although AAA Medic does not yet generate any revenue. Four weeks ago, it began construction of a 10,000-square-foot marijuana cultivation facility in Laval, Que., about an hour from Montreal. The company has since changed its mind about cultivation at this facility; it now plans to build a 10,000-square-foot marijuana processing facility. Processing will include oil extraction and product development. AAA Medic expects to finish construction in the first quarter of 2019. That is also when the shell expects to close the QT. The shell, which has 18,946,180 shares issued, will issue 62,438,500 shares to its target's shareholders.

AAA Medic plans to build another facility, a 150,000-square-foot cultivation and oil-extraction facility in Sainte-Luce, Que., about 5-1/2 hours northeast of Montreal. The company expects to spend $35-million on this facility, and it aims to begin construction in the second half of 2019. Before then, AAA Medic plans to buy 51 per cent of the production from a proposed 34,000-square-foot facility in Kanesatake, Que., a territory of the Mohawks. To partially finance this Mohawk facility, as well as the above-mentioned Laval facility, AAA Medic plans to raise between $5-million and $9-million. It has not yet set the financing terms. According to documents filed with the B.C. Securities Commission, AAA Medic sold $2-million worth of shares at 20 cents to about 30 investors between June and August.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed